Clinical trial template

High Density Lipoprotein Microchapters

Home

Patient information

Overview

Historical Perspective

Classification

Physiology

Pathophysiology

Causes

Low HDL
High HDL

Epidemiology and Demographics

Screening

Natural History, Complications and Prognosis

Diagnosis

HDL Laboratory Test

Treatment

Medical Therapy

Prevention

Future or Investigational Therapies

Clinical Trials

Landmark Trials

List of All Trials

Case Studies

Case #1

Clinical trial template On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Clinical trial template

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Clinical trial template

CDC on Clinical trial template

Clinical trial template in the news

Blogs on Clinical trial template

Directions to Hospitals Treating High density lipoprotein

Risk calculators and risk factors for Clinical trial template

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

## Official Title

[edit | edit source]

## Objective

[edit | edit source]

## Sponsor

[edit | edit source]

## Timeline

[edit | edit source]

Timeline

Start Date |
Run-In Period |
End Date |
Status |

The previous information was derived from ClinicalTrials.gov on 09/20/2013 using the identification number NCT

.

## Study Description

[edit | edit source]

Study Description

Study Type |
Study Phase |
Study Design
Allocation |
Endpoint |
Interventional Model |
Masking |
Study Details
Primary Purpose |
Condition |
Intervention |
Study Arms |
Population Size |

The previous information was derived from ClinicalTrials.gov on 09/20/2013 using the identification number NCT
--.

## Eligibility Criteria

[edit | edit source]

### Inclusion Criteria

[edit | edit source]

### Exclusion Criteria

[edit | edit source]

## Outcomes

[edit | edit source]

### Primary Outcomes

[edit | edit source]

### Secondary Outcomes

[edit | edit source]

## Publications

[edit | edit source]

### Results

[edit | edit source]

### Conclusion

[edit | edit source]

## References

[edit | edit source]

* v
* t
* e

Lipopedia

Basic Science|

Cholesterol • Triglyceride

Lipoprotein metabolism and transport

Lipoprotein: Chylomicron • Chylomicron remnant • HDL • IDL • LDL • Lipoprotein(a) • VLDL • Lipoprotein-X

Apolipoprotein: APOA (1, 2, 4,  5) • APOB ( Apolipoprotein B-48, Apolipoprotein B-100) • APOC (1, 2, 3, 4) • APOD • APOE • APOH • APOJ • APOL • APOM • Apo(a)

Lipoprotein receptor: LDL receptor • Soluble low density lipoprotein receptor-related protein (sLRP) • Apolipoprotein E Receptor 2 • Scavenger receptor • Scavenger receptor A • Scavenger receptor B • VLDL receptor

Lipoprotein enzymes: Lipoprotein lipase • Lipoprotein-associated phospholipase A2 (Lp-PLA2) • Cholesterylester transfer protein ( Acetyl-CoA C-acyltransferase, Lecithin-cholesterol acyltransferase) • Microsomal triglyceride transfer protein • ABCA1

Genes: Low density lipoprotein receptor gene family • Microsomal triglyceride transfer protein • ABCA1

Lipoprotein Disorders|

Lipoprotein disorders

Primary lipoprotein disorders: Familial hyperchylomicronemia (Type I) • Familial hypercholesterolemia (Type IIA) • Familial combined hyperlipidemia (Type IIB) • Dysbetalipoproteinemia (Type III) • Primary hypertriglyceridemia (Type IV) • Mixed hyperlipoproteinemia (Type V)

Secondary lipoprotein disorders

Abnormal Laboratory Lipid Profile|

Low chylomicron • Low chylomicron remnant • Low HDL • Low IDL • Low LDL • Low lipoprotein(a) • Low VLDL

High chylomicron • High chylomicron remnant • High HDL • High IDL • High LDL • High Lipoprotein(a) • High VLDL
*[v]: View this template
*[t]: Discuss this template
*[e]: Edit this template